BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23023569)

  • 1. Stem cell themes: promises and challenges.
    Glicksman M; Pajak L; Lam K
    J Biomol Screen; 2012 Oct; 17(9):E1-3. PubMed ID: 23023569
    [No Abstract]   [Full Text] [Related]  

  • 2. Converging technologies to enable induced pluripotent stem cells in drug discovery.
    Flynn P; Yingling J; Shoemaker D
    Regen Med; 2010 Jul; 5(4):489-91. PubMed ID: 20632850
    [No Abstract]   [Full Text] [Related]  

  • 3. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise review: a high-content screening approach to stem cell research and drug discovery.
    Xia X; Wong ST
    Stem Cells; 2012 Sep; 30(9):1800-7. PubMed ID: 22821636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
    McGivern JV; Ebert AD
    Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of human embryonic stem cells in drug discovery. Counterpoint.
    Esteso P; Gearhart JD
    Clin Pharmacol Ther; 2011 May; 89(5):641-3. PubMed ID: 21512522
    [No Abstract]   [Full Text] [Related]  

  • 7. iPSC technology: platform for drug discovery. Point.
    Ellis J; Bhatia M
    Clin Pharmacol Ther; 2011 May; 89(5):639-41. PubMed ID: 21512521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic approaches to dissect biological processes in stem cells by image-based screening.
    Erdmann G; Volz C; Boutros M
    Biotechnol J; 2012 Jun; 7(6):768-78. PubMed ID: 22653826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pluripotent stem cells for disease modelling and drug screening.
    Maury Y; Gauthier M; Peschanski M; Martinat C
    Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stem cells and drug screening: opportunities and challenges.
    Ebert AD; Svendsen CN
    Nat Rev Drug Discov; 2010 May; 9(5):367-72. PubMed ID: 20339370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pluripotent stem cells: the development of high-content screening strategies.
    Sherman SP; Alva JA; Thakore-Shah K; Pyle AD
    Methods Mol Biol; 2011; 767():283-95. PubMed ID: 21822883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NMR in the fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
    [No Abstract]   [Full Text] [Related]  

  • 14. The challenges and promises of blood engineered from human pluripotent stem cells.
    Dravid GG; Crooks GM
    Adv Drug Deliv Rev; 2011 Apr; 63(4-5):331-41. PubMed ID: 21232565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Practice of fragment-based lead discovery by X-rays].
    Yamano A
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1622-7. PubMed ID: 21089598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fragment-based lead discovery from smaller fragments to functional ligand].
    Hatayama A; Habashita H
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling embryonic stem cell growth and differentiation by automation: enhanced and more reliable differentiation for drug discovery.
    Kowalski MP; Yoder A; Liu L; Pajak L
    J Biomol Screen; 2012 Oct; 17(9):1171-9. PubMed ID: 22895460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput screening for biomaterials discovery.
    Algahtani MS; Scurr DJ; Hook AL; Anderson DG; Langer RS; Burley JC; Alexander MR; Davies MC
    J Control Release; 2014 Sep; 190():115-26. PubMed ID: 24993427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.